Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
West China Hospital
West China Hospital
Centre Hospitalier Universitaire Dijon
Methodist Health System
Huazhong University of Science and Technology
University of California, Davis
Memorial Sloan Kettering Cancer Center
National Institute of Cardiology, Warsaw, Poland
European Institute of Oncology
Assistance Publique - Hôpitaux de Paris
University of Nebraska
IRCCS San Raffaele
First Affiliated Hospital of Zhejiang University
University Hospital, Strasbourg, France
University of Iowa
Hospices Civils de Lyon
University Health Network, Toronto
University Hospital, Brest
British Columbia Cancer Agency
Hospices Civils de Lyon
Tongji Hospital
IRCCS San Raffaele
Nanjing First Hospital, Nanjing Medical University
University of Roma La Sapienza
Grupo Espanol de Tumores Neuroendocrinos
Western Sydney Local Health District
First Affiliated Hospital, Sun Yat-Sen University
Jagiellonian University
Latin American Cooperative Oncology Group
Central Hospital, Nancy, France
University of Pennsylvania
University Hospital, Basel, Switzerland
Asan Medical Center
European Institute of Oncology
Istituto Clinico Humanitas
Insel Gruppe AG, University Hospital Bern
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fujian Maternity and Child Health Hospital
Universidad Nacional Autonoma de Mexico
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University Medical Center Groningen
University Medical Center Groningen
University Medical Center Groningen
University Medical Center Groningen
University Medical Center Groningen
European Institute of Oncology
Peking Union Medical College Hospital
European Institute of Oncology
IRCCS San Raffaele
Qilu Hospital of Shandong University
IRCCS San Raffaele